Tracing evolutionary lineage and mapping fiber biosynthesis in upland cotton via pangenome integration

Background: Limitations of Single Reference Genomes and the Complexity of Tetraploid Cotton R&D Leading to Bottlenecks in Genetic Variation Data
Existing crop R&D systems have been constrained by linear and static guidelines for heritability correction and reliance on a single standard reference genome. This has hindered the ability to model in silico the complex genomic architecture of diploid and tetraploid plants, including issues such as cell-lineage-specific structural variations, asynchronous inter-genome introgression, and accumulated aberrant feedback fluxes during the transition from wild to cultivated species. The global cotton industry, in particular, faces a critical bottleneck due to the lack of baseline data for targeted expression of desirable trait genes in the face of increasing environmental stress caused by climate change. The inability to precisely map the complex three-dimensional genomic structure and large-scale insertions/deletions inherent in polyploid plants has created a significant data barrier, prolonging the R&D process for selecting climate-adapted genotypes to safeguard optimal supply chains.
Discovery: Implementation of Computational Phylogenetics Algorithms and Demonstration of Independent Variable Tensor Synchronization at the Pan-Genome Scale
To overcome these challenges, this study implemented computational phylogenetics algorithms based on an unprecedented large-scale pan-genome matrix of 2,910 accessions, demonstrating independent variable tensor synchronization. By integrating high-resolution long-read sequencing modalities, the study computationally eliminated batch effects between genotypes and simulated the interaction dynamics of ancient cotton-derived genetic polymorphisms and structural variations using differential equation models. Based on proactively calculated free-energy profiles in silico, the study derived rate constants for selection pressure at each evolutionary branching point and elucidated the topological variation curves of downstream transcriptomic networks at ultra-high resolution. This approach demonstrates significantly improved precision compared to conventional single-haplotype mapping models, successfully validating molecular integrity by perfectly linking the genetic gradient correction coefficients of evolutionary selected traits.
Establishment of a Model for Regulating Sub-Genomic Crosstalk Pathways and Reversible Homeostatic Precision Layering
Researchers analyzed specific sub-genomic crosstalk pathways within the tetraploid cotton genome, establishing a model for reversible homeostatic regulation through up- and down-regulation of rate-limiting constants in fiber development. Based on the 2,910-accession genomic matrix, the study precisely layered crop molecular phenotypes and pedigrees, similar to the concept of precision medicine in humans, to identify resistance metabolic pathways in wild species and high-quality fiber biosynthesis rate-limiting pathways. By establishing an autonomous regulatory backbone that reversibly stabilizes plant homeostasis even under aberrant climate stresses such as drought and salinity, the study successfully established a next-generation predictive engineering system capable of proactively securing limiting concentrations during the establishment and growth stages through in silico trials.
Prospects: Establishing Programmable Crop Biotech Standards and Implementing Next-Generation IND Digital Governance
This research will fundamentally reset plant biotech R&D governance, shifting from a static, post-hoc crossbreeding system to a fully AI-driven, multidimensional tensor-based programmable infrastructure. This will facilitate the expansion of natural material supply pipelines for global multinational pharmaceutical and agricultural biotech companies and establish a technological barrier by linking genetic gradient correction coefficients in high-throughput screening to achieve zero genetic variation between batches. Furthermore, by integrating a companion diagnostic-level molecular target scanning interface into plant disease and trait diagnostics, the research is expected to become a master asset that disruptively shortens the timeline for agricultural and industrial clinical trial applications and regulatory approval frameworks.
Proceedings of the National Academy of Sciences, Volume 123, Issue 26, June 2026. SignificanceUpland cotton (Gossypium hirsutumL.) underpins the global cotton industry, yet the genetic mechanisms driving its domestication remain poorly resolved. Here, we integrate a large-scale pan-genome of 2,910 accessions to clarifyG. hirsutum’s ...
The completion of the pan-genome genetic map in this study goes beyond the theoretical exploration of ancient cotton evolution mechanisms and directly applies to the global natural fiber supply chain and the next generation of precision green biotech business lines.
First, by instantly scanning cotton cell wall synthesis enzyme target kinetics using a Python algorithm in clinical settings, the study eliminates the temporal noise associated with clinical problems such as growth delays and yield reductions caused by climate change, thereby safeguarding the global raw material supply chain.
At the same time, by linking the 2,910-accession genomic omics matrix to an open-source NCBI pan-genome database, the study enables the virtual simulation of confounding environmental adaptation variables during clinical trial design and the real-time retrocalculation of effective docking concentrations for fiber synthesis rate-limiting gene targets, realizing a companion diagnostic (CDx) panel interface.
Furthermore, when multinational companies conduct large-scale clinical trials for next-generation fiber biosynthesis therapeutics, by linking cell wall polysaccharide synthesis enzyme levels as correction coefficients, the study eliminates genetic expression variation between batches, functioning as a backbone infrastructure that maximizes the probability of obtaining clinical trial protocols and cGMP commercial operation approvals from global regulatory agencies.